Tomeko — every condition, connected. Open full hub →
Home  /  Disease hubs  /  Mucopolysaccharidosis type 1

Mucopolysaccharidosis type 1

Specialists and centers, recruiting clinical trials, patient organizations, research, and community for Mucopolysaccharidosis type 1 — brought together in one place.

Open the full interactive hub for Mucopolysaccharidosis type 1 →

Find specialists Clinical trials Patient organizations Research & market

Just diagnosed with Mucopolysaccharidosis type 1?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Mucopolysaccharidosis type 1, look for clinical trials, and connect with others living with it — all in one place.

Open the full interactive Mucopolysaccharidosis type 1 hub →

Overview

Mucopolysaccharidosis type 1 is a rare condition. Also known as Alpha-L-iduronidase deficiency, MPS1, MPSI, Mucopolysaccharidosis type I. Tomeko brings together the specialists, research, clinical trials, treatments and community for Mucopolysaccharidosis type 1 so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:579 · OMIM 607014, 607015, 607016 · ICD-10 E76.0 · GARD 0010335

Find care for Mucopolysaccharidosis type 1

Authoritative references for Mucopolysaccharidosis type 1

Research & market landscape for Mucopolysaccharidosis type 1

Following Mucopolysaccharidosis type 1 for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Mucopolysaccharidosis type 1 — the real-world landscape behind the condition, in one place.

Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Mucopolysaccharidosis type 1 and every rare condition. See how Tomeko works with industry →

Common questions

What is Mucopolysaccharidosis type 1?

Mucopolysaccharidosis type 1 is a rare condition. Also known as Alpha-L-iduronidase deficiency, MPS1, MPSI, Mucopolysaccharidosis type I. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Mucopolysaccharidosis type 1 together in one place.

What are the symptoms of Mucopolysaccharidosis type 1?

Symptoms of Mucopolysaccharidosis type 1 vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Mucopolysaccharidosis type 1.

How is Mucopolysaccharidosis type 1 treated?

Treatment for Mucopolysaccharidosis type 1 depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Mucopolysaccharidosis type 1, and review current options with them.

What causes Mucopolysaccharidosis type 1 — is it genetic?

The cause and inheritance of Mucopolysaccharidosis type 1 are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Mucopolysaccharidosis type 1 can explain what it means for you and your family.

I was just diagnosed with Mucopolysaccharidosis type 1 — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Mucopolysaccharidosis type 1, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Mucopolysaccharidosis type 1?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Mucopolysaccharidosis type 1, filtered to your area.

Are there clinical trials for Mucopolysaccharidosis type 1?

Tomeko shows live, recruiting studies for Mucopolysaccharidosis type 1 from ClinicalTrials.gov on the hub.

Related conditions

Other conditions on Tomeko you may be looking for: